右心室 - 肺动脉合作为心脏 Amyloidosis 的预后标记: 一个全面的审查
Nikolaos Tsiamis1, Dimitrios Afendoulis2, Christos Tountas1
1Cardiology Department, Sismanogleio General Hospital, 15126 Athens, Greece.
右心室 - 肺动脉 (RV-PA) 合是心肌粉症 (CA) 的关键预后标志物. 通过TAPSE/PASP比率评估的受损的RV-PA合,可以识别高风险患者,并有助于临床决策.
科学领域:
- 心脏病学 心脏病学
- 心血管成像 - 心血管成像
- 氨基粉症研究研究
背景情况:
- 心脏粉症 (CA) 是由于心肌透导致心力衰竭的原因.
- 左心室功能传统上指导预后,但右心室 (RV) 功能障碍和RV-肺动脉 (PA) 合越来越被认为是关键的结果决定因素.
研究的目的:
- 审查目前关于RV-PA合作为CA的预后标记物的证据.
- 检查测量方法,预后意义,病理生理学和RV-PA合在CA中的临床应用.
主要方法:
- 关于在AL和ATTR心脏粉症中RV-PA合的研究 (2020-2025) 的综合文献综述.
- 分析多中心队列,注册表和验证研究,将RV-PA合指数与临床结果联系起来.
主要成果:
- 通常通过TAPSE/PASP比率测量的RV-PA合显示了CA患者死亡率和心力衰竭的强有力的独立预后价值.
- 损伤合 (TAPSE/PASP < 0.45 mm/mmHg) 识别了高风险个体,不良结果的危险比率从 1.98 到 4.17.
- TAPSE/PASP比率通过结合后载,在单个RV参数上提供增量预测值,在AL和ATTR亚型中表现一致.
结论:
- RV-PA 合是一种强大的,易于获得的CA风险分层和临床决策的预后标记.
- TAPSE/PASP比率对于例行心声回声评估是实用的,提供了重要的预后信息.
- 未来的研究应该标准化协议,定义值,并将合评估整合到CA管理策略中.
更多相关视频
09:40Induction of Right Ventricular Failure by Pulmonary Artery Constriction and Evaluation of Right Ventricular Function in Mice
Published on: May 13, 2019
07:02A Large Animal Model for Pulmonary Hypertension and Right Ventricular Failure: Left Pulmonary Artery Ligation and Progressive Main Pulmonary Artery Banding in Sheep
Published on: July 15, 2021
相关概念视频
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
